Market Overview:
The global eriocitrin market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising demand for natural ingredients in food and beverage products, increasing awareness about the health benefits of eriocitrin, and growing demand for functional foods. However, stringent regulatory norms regarding use of synthetic additives in food products may hamper the growth of this market. On the basis of type, less than 98% segment is expected to account for a major share in terms of revenue in 2018. This can be attributed to high demand for natural ingredients by consumers across regions. On the other hand, more than 98% segment is projected to witness higher CAGR during forecast period owing to increasing application areas such as research and medical sector. Regionally, North America dominates global eriocitrin market followed by Europe due high consumer awareness about health benefits associated with consumption of functional foods and beverages containing natural ingredients including eriocitrin extract.
Product Definition:
A flavonoid glycoside found in citrus fruits and other plants. It is a colorless to yellow crystalline solid with a slightly bitter taste. Eriocitrin is used as a natural food colorant and has antioxidant properties.
Less Than 98%:
It is a type of flavonoid, found in the plant families Solanaceae and Brassicaceae. The main source of less than 98% is citrus fruits such as lemon, orange and grapefruit. Other sources include cranberries, tea leaves, rosemary needles and wheat bran among others.
More Than 98%:
More than 98% is a technical term used for the concentration of flavanols in cocoa that contains more than 2.0% of flavonoids by weight. More Than 98% (M98%) has several health benefits such as it helps to reduce the risk of cardiovascular diseases, improves blood flow and oxygen supply to tissues, enhances immune function, and prevents cancer cell growth.
Application Insights:
The research application segment led the global market in 2017. The product is used as a natural dietary supplement and for the treatment of heart diseases, high blood pressure, diabetic retinopathy and glaucoma. It is also employed in cosmetics as an anti-aging agent to improve skin texture.
Eriocitrin has been approved by U.S FDA under GRAS (Generally Recognized As Safe) status for use in food supplements and cosmetics applications respectively. However, it faces competition from other similar compounds present in nature such as citric acid which has a wider scope of application owing to its lower toxicity levels compared to eriocitrin products manufactured through chemical synthesis processes.
Regional Analysis:
North America was the leading regional market in 2017. The region is expected to maintain its position throughout the forecast period owing to high awareness regarding obesity and overweight, which has encouraged people to consume less citrinin products. In addition, growing health concerns over sugar content in beverages are anticipated to further drive demand for eriocitrin-based products over the coming years.
Asia Pacific is projected to be one of the fastest-growing regions during the same period owing to increasing product consumption as a dietary supplement in countries such as China and India.
Growth Factors:
- Increasing demand for natural and organic products
- Rising awareness about the health benefits of citrus fruits
- Growing popularity of functional foods and beverages
- Proliferation of retail outlets that sell citrus fruits and juices
- Expanding global trade in citrus fruits
Scope Of The Report
Report Attributes
Report Details
Report Title
Eriocitrin Market Research Report
By Type
Less Than 98%, More Than 98%
By Application
Research, Medical
By Companies
BOC Sciences, Carl ROTH, BLDpharm, Pharmaffiliates, ChemScence, AdooQ BioScience, ApexBio Technology, EXTRASYNTHESE, Merck, Targetmol, Cayman Chemical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
127
Number of Tables & Figures
89
Customization Available
Yes, the report can be customized as per your need.
Global Eriocitrin Market Report Segments:
The global Eriocitrin market is segmented on the basis of:
Types
Less Than 98%, More Than 98%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research, Medical
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BOC Sciences
- Carl ROTH
- BLDpharm
- Pharmaffiliates
- ChemScence
- AdooQ BioScience
- ApexBio Technology
- EXTRASYNTHESE
- Merck
- Targetmol
- Cayman Chemical
Highlights of The Eriocitrin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Less Than 98%
- More Than 98%
- By Application:
- Research
- Medical
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Eriocitrin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Eriocitrin is a naturally occurring compound found in red grapefruit juice. It has been shown to have antioxidant properties and may help protect the body against damage caused by free radicals.
Some of the key players operating in the eriocitrin market are BOC Sciences, Carl ROTH, BLDpharm, Pharmaffiliates, ChemScence, AdooQ BioScience, ApexBio Technology, EXTRASYNTHESE, Merck, Targetmol, Cayman Chemical.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Eriocitrin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Eriocitrin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Eriocitrin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Eriocitrin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Eriocitrin Market Size & Forecast, 2020-2028
4.5.1 Eriocitrin Market Size and Y-o-Y Growth
4.5.2 Eriocitrin Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Less Than 98%
5.2.2 More Than 98%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research
6.2.2 Medical
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Eriocitrin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Eriocitrin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Less Than 98%
9.6.2 More Than 98%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research
9.10.2 Medical
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Less Than 98%
10.6.2 More Than 98%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research
10.10.2 Medical
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Less Than 98%
11.6.2 More Than 98%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research
11.10.2 Medical
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Less Than 98%
12.6.2 More Than 98%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research
12.10.2 Medical
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Less Than 98%
13.6.2 More Than 98%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research
13.10.2 Medical
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Eriocitrin Market: Competitive Dashboard
14.2 Global Eriocitrin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BOC Sciences
14.3.2 Carl ROTH
14.3.3 BLDpharm
14.3.4 Pharmaffiliates
14.3.5 ChemScence
14.3.6 AdooQ BioScience
14.3.7 ApexBio Technology
14.3.8 EXTRASYNTHESE
14.3.9 Merck
14.3.10 Targetmol
14.3.11 Cayman Chemical
